During the COVID-19 emergency, there has been a delay of elective surgery which has caused a significant reduction of treatment of heart valve disease. Combined with scarce diagnostic capacities this leads to undertreatment of patients. This gap must be closed through a screening action.
- Does the government agree that it is important to adopt initiatives to reduce the number of missed diagnoses?
- Does the government intend to monitor the impact of the pandemic on the levels of treatment of heart valve disease and to undertake initiatives to correct possible delays of patient treatments?